COP
42
-3
MDLZ
53
2
BF.B
47
-4
CFG
79
-16
PCAR
36
-3
DHR
58
-5
DVN
32
-4
CMG
54
-3
RIG
11
-5
V
40
2
CVX
37
-3
CMCSA
48
4
EBAY
59
10
IFF
63
-2
HSIC
50
-7
KMB
42
-2
COF
72
12
EMR
71
9
HUM
43
-2
MCO
62
3
COP
42
-3
MDLZ
53
2
BF.B
47
-4
CFG
79
-16
PCAR
36
-3
DHR
58
-5
DVN
32
-4
CMG
54
-3
RIG
11
-5
V
40
2
CVX
37
-3
CMCSA
48
4
EBAY
59
10
IFF
63
-2
HSIC
50
-7
KMB
42
-2
COF
72
12
EMR
71
9
HUM
43
-2
MCO
62
3
Financhill
Back

Royal Gold Vs. Kymera Therapeutics Industry Stock Comparison

Sell
49

RGLD
Royal Gold

Last Price:
$159.76
Seasonality Move:
7.69%
Buy
58

KYMR
Kymera Therapeutics

Last Price:
$44.92
Seasonality Move:
5.78%
Sell
49
Royal Gold (RGLD) is a Sell

Is Royal Gold a Buy, Sell or Hold?

  • The current Royal Gold [RGLD] share price is $159.82. The Score for RGLD is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • RGLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $44.90. The Score for KYMR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RGLD Stock Price Chart

What is Royal Gold's stock price today?

  • The Royal Gold share price today is $159.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGLD is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $44.90
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

RGLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 39.48 Buy
Relative Strength Index (14 RSI): 31.46 Sell
Chaikin Money Flow: -674997 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (166.6 - 181.92) Sell
Bollinger Bands (100): (156.68 - 181.84) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 11.04 Buy
Relative Strength Index (14 RSI): 56.78 Buy
Chaikin Money Flow: -176499 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.38 - 47.28) Sell
Bollinger Bands (100): (27.35 - 42.63) Buy

RGLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 165.94 Sell
20-day SMA: 173.83 Sell
50-day SMA: 176.18 Sell
200-day SMA: 156.08 Buy
8-day EMA: 114.44 Buy
20-day EMA: 63 Buy
50-day EMA: 29.01 Buy
200-day EMA: 7.81 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.54 Buy
20-day SMA: 45.33 Sell
50-day SMA: 39.36 Buy
200-day SMA: 39.49 Buy
8-day EMA: 32 Buy
20-day EMA: 17.59 Buy
50-day EMA: 8.1 Buy
200-day EMA: 2.18 Buy

Royal Gold Earnings Growth & RGLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.84 per share, a decrease next quarter of $0.26 per share, an increase this year of $2.31 per share, and an increase next year of $0.88 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.41 per share.

Royal Gold Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):